Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies

Published:2024-12 Issue: Volume:279 Page:116831
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

I Aayishamma,Purawarga Matada Gurubasavaraja Swamy^ORCID,Pal Rohit^ORCID,Ghara Abhishek,Aishwarya Nimmagadda Venkata Satya Sai,B Kumaraswamy,Hosamani Ketan R.,B V Manjushree,E Haripriya

Publisher

Elsevier BV

Reference96 articles.

1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2024

2. A review on anticancer potentials of benzothiazole derivatives;Pathak;Mini Rev. Med. Chem.,2020

3. An updated literature on BRAF inhibitors (2018–2023);Maji;Mol. Divers.,2023

4. Global Cancer Statistics 2022: the trends projection analysis;Chhikara;Chem. Biology Lett.,2023

5. An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC);Pal;J. Biomol. Struct. Dyn.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP